The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I/II study to evaluate the efficacy of TAS0313, a cancer peptide vaccine, combined with pembrolizumab for locally advanced or metastatic urothelial carcinoma.
 
Ryuji Matsumoto
No Relationships to Disclose
 
Junji Yonese
No Relationships to Disclose
 
Takashi Kawahara
No Relationships to Disclose
 
Hideaki Miyake
Honoraria - Merck; MSD; Pfizer
Research Funding - MSD (Inst); Pfizer (Inst)
 
Nobuaki Matsubara
Honoraria - AstraZeneca; Bayer; Chugai Pharma (Inst); Janssen; MSD
Consulting or Advisory Role - AstraZeneca; Janssen; Lilly; Sanofi
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bayer Yakuhin (Inst); Chugai Pharma (Inst); Janssen (Inst); MSD (Inst)
 
Hiroji Uemura
Honoraria - Astellas Pharma; Bayer Yakuhin; Janssen Oncology; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; AstraZeneca; Bayer Yakuhin; Janssen Oncology; Takeda
 
Masatoshi Eto
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Chugai Pharma; Eisai; Johnson & Johnson; Merck; Ono Pharmaceutical; Pfizer; Takeda
Speakers' Bureau - Bristol-Myers Squibb; Janssen Oncology; Merck; MSD Oncology; Novartis; Ono Pharmaceutical; Pfizer; Takeda
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Ono Pharmaceutical (Inst); Sanofi (Inst); Takeda (Inst)
 
Haruhito Azuma
No Relationships to Disclose
 
Wataru Obara
Speakers' Bureau - Bristol-Myers Squibb Japan; MSD; Ono Pharmaceutical
Research Funding - Abbvie (Inst); Asahi Kasei (Inst); Chugai Pharma (Inst); Ono Pharmaceutical (Inst); Otsuka (Inst); Takeda (Inst)
 
Akito Terai
No Relationships to Disclose
 
Satoshi Fukasawa
No Relationships to Disclose
 
Shigetaka Suekane
No Relationships to Disclose
 
Hiroyuki Nishiyama
Honoraria - MSD
Consulting or Advisory Role - Bayer Yakuhin; Chugai Pharma; Janssen; Lilly; MSD
Speakers' Bureau - Chugai Pharma; MSD; Olympus
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Ono Pharmaceutical (Inst); Takeda (Inst)